Pharma group Merck calls £100m international media review

Merck, the global healthcare company, is set to review its estimated £100 million international media business.

Clarityn: media by Publicis
Clarityn: media by Publicis

It is understood that the review will focus on international markets excluding the US.

The client has contacted networks ahead of a review.

ZenithOptimedia handles UK media for Clarityn, which was awarded to the agency in 2008 when the brand was owned by Schering-Plough. It also looks after a range of Merck brands in Australia.

Initiative, which shares the US media account with its sister Interpublic agency DraftFCB, also has some of the business in Europe.

Interpublic was awarded the consolidated US business in March 2010, when Merck called a review after its merger with Schering-Plough.

Merck did not return calls when Campaign went to press.

Subscribe to Campaign from just £57 per quarter

Includes the weekly magazine and quarterly Campaign IQ, plus unrestricted online access.

SUBSCRIBE

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an Alert Now

Just published

More